|
|
||||||||
Ann Thorac Surg 2004;77:563-568
© 2004 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, University of Miami/Jackson Memorial Hospital, Miami, Florida, USA
* Address reprint requests to Dr Katariya, Cardiothoracic Surgery, University of Miami, 1611 NW 12th Ave, ET 3072, Miami, FL 33133, USA.
e-mail: kkatariya{at}med.miami.edu
Presented at the Thirty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Diego, CA, Jan 31Feb 2, 2003.
| Abstract |
|---|
|
|
|---|
METHODS: Between November 2001 and August 2002, 206 saphenous vein to aorta proximal anastomoses were created in 132 patients using the Symmetry device. All procedures were performed as part of off-pump coronary artery bypass surgery without any aortic clamping. Intraoperative variables and postoperative data were collected and analyzed retrospectively.
RESULTS: All 206 anastomoses (100%) were successfully completed with the connector. Severe atherosclerotic disease of the aorta was documented in 16 patients (12%). Four anastomoses (2%) required additional suture placement. Predeployment problems occurred with 3 grafts (2.5%) during loading of the connector. Average number of distal bypasses was 3.2 per patient. One patient (0.7%) required reoperation for bleeding from a proximal anastomosis. Six patients (4.5%) had perioperative myocardial infarction documented by electrocardiographic changes. Thirty-day operative mortality was 3% (4 patients). Intraoperative transit time flow measurement was performed in all cases (100%). Postoperative angiography in 43 patients at a median 3 months postoperatively revealed occlusion of 9 of the 81 saphenous vein grafts (11%).
CONCLUSIONS: The initial experience with a proximal saphenous vein graft to aorta anastomosis using the Symmetry connector demonstrates safety and ease of use. There is however some concern with early graft closure. A prospective randomized study is needed to clarify these concerns.
| Introduction |
|---|
|
|
|---|
The St. Jude Symmetry (St. Paul, MN) aortic connector system (ACS) was developed to allow creation of saphenous vein graft (SVG) to aorta anastomosis without the use of sutures or partial or total aortic cross clamping. This device received European certification in May 2000 and Food and Drug Administration approval in May 2001. We report our experience to date with 206 deployments in 132 patients.
| Patients and methods |
|---|
|
|
|---|
The Symmetry ACS uses a self-expanding nitinol stent that creates an anastomosis by anchoring the vein graft to the aorta without any sutures. The Symmetry ACS is designed to create the proximal anastomosis between the SVG and the aorta before the distal is constructed. Insertion is a simple process performed without aortic cross clamping. Before loading the vein on to the ACS, the external diameter of the SVG is assessed using a color-coded sizer to allow selection of the appropriate sized Symmetry ACS. The next step creates the aortotomy with the specially designed cutter that corresponds to the size of the connector being used. The aortic cutter is then removed from the aortotomy and is replaced with the connector that has the vein loaded onto it. The final step involves firing the connector, which deploys the nitinol stent that anchors the SVG to the aorta. A detailed description of the Symmetry ACS is reported elsewhere by Eckstein and colleagues [4].
Preoperative patient characteristics are shown in Table 1. All proximal SVG to aorta anastomoses were created with the ACS. A total of 249 distal SVG anastomoses were created with 43 (17%) being sequential anastomoses. Of these, 107 distals were to the obtuse marginal branches of the circumflex coronary artery, 93 to the right coronary artery territory, 39 to diagonal branches of the left anterior descending (LAD) artery, and 10 to left anterior descending artery (Table 2). Of the 206 connectors deployed, 69 were color-coded gray (4.5 to 5.0 mm), 88 green (5.0 to 5.5 mm), 35 blue (5.5 to 6.0 mm), and 14 purple (6.0 to 7.0 mm). The left internal thoracic artery (LITA) was used in 124 patients (94%).
|
|
| Results |
|---|
|
|
|---|
|
All patients were called back for postoperative coronary angiography. Forty-three patients (32.6%) underwent a postoperative cardiac catheterization, which was performed at a median of 3 months after surgery. Of these, 8 patients (18.6%) had symptoms of cardiac origin and 35 patients (81.4%) were asymptomatic. This enabled follow-up of 135 grafts including SVG to 81 distal targets. A total of nine grafts (11%) in 6 patients were occluded with no sign of retrograde filling (Table 4). In this group of 6 patients, 2 had closure of all their grafts including the LITA. The other 4 patients had closure of each of their ACS vein grafts but the LITA grafts were patent.
|
|
|
|
| Comment |
|---|
|
|
|---|
The first description of a mechanically facilitated vascular anastomosis was by Androsov [7] from Russia who used a stapler to create an end-end vascular anastomosis in 71 patients. Subsequently modified designs of this stapler were used in the United States by Mallina, in Japan by Inokuchi, and in Canada by Vogelfanger [8]. Owing to the cumbersome loading process and the necessity of having essentially normal blood vessels, these designs fell into disfavor. More recently Calafiore and associates [9] reported the use of a proximal anastomotic device in 17 patients undergoing coronary bypass surgery. With the advent and increasing popularity of OPCAB there has been renewed interest in the use of vascular anastomotic devices.
The incidence of severe neurologic complication after coronary artery bypass surgery is 1% to 6% [1011]; manipulation of the aorta is a significant cause of microembolization of particulate matter to the brain leading to the neurologic morbidity seen during coronary revascularization procedures. Landolfo in as yet unpublished data studies has shown that the number of microemboli detected by transcranial doppler ultrasonography was reduced significantly (mean 29.5, 99% confidence interval, 15.2 to 43.8) when the Symmetry ACS was used to create SVG-aorta proximal anastomosis as compared with the conventional hand sewn anastomosis with a partial occlusion aortic clamp (mean 304.6, 99% confidence interval, 161.5 to 447.7) [3]. He suggested that the majority of microemboli are the result of clamping or unclamping the aorta, whether it is a partial or total. Palpation is an inaccurate technique to judge the presence of atheromatous plaque inside the ascending aorta and may be the source of these atheroemboli released by clamping. The ability to perform OPCAB without aortic clamping is therefore clearly desirable in order to lower neurologic morbidity. Therein lays the advantage of the Symmetry ACS. Furthermore, creation of proximal anastomoses with the Symmetry ACS is quick and reproducible and has a low complication rate in our small retrospective series. There is a learning curve in loading the vein on the device which is neither steep nor long.
Disadvantages of using the Symmetry connector include the need to complete the proximal anastomosis before creating the distal anastomosis. With current technologic limitations the connector is not available for use with arterial conduits. The other major disadvantage of the Symmetry connector is the inability to bevel the end of the SVG at the proximal anastomotic site. This leads to a 90-degree take-off angle of the SVG from the ascending aorta that may predispose to kinking of the conduit. Appropriate positioning of the anastomosis on the ascending aorta is essential to avoid this problem. We recommend selection of the antero-lateral aspect of the aorta as proximal anastomotic site when using the Symmetry ACS with special attention to the measurement of the graft length to avoid kinking of the vein graft.
Our ACS vein graft occlusion rate is 11% at a median interval of 3 months after surgery. Two of the 6 patients in this group had closure of all grafts including the LITA. One of these 2 patients in whom all grafts were occluded was later found to have a hypercoagulable state with positive lupus anticoagulant and protein S deficiency. In view of the fact that intraoperative flowmetry of the grafts was performed and found to be satisfactory in these patients, the chance of technical error in all of these grafts appears to be small. A possible explanation is a hypercoagulable state either related to OPCAB surgery as has been proposed by Kim and colleagues [12] or to a preexisting and inherent hypercoagulable in the patient. We did note a trend in the occlusion rate with the use of smaller size connectors (4.5 to 5 mm) although this was not statistically significant. The use of a smaller size ACS owing to small vein diameter could be associated with poorer quality conduit, which could contribute to graft closure. The design of the Symmetry ACS is such that the anchoring nitinol stent is exposed to the blood elements on the inside of the anastomosis. As is seen with intracoronary stents this may elicit two responses that may lead to graft closure. The first is acute in-stent thrombosis, which typically occurs in smaller size stents particularly within the first 2 weeks of insertion. The second is in-stent restenosis due to intimal hyperplasia occurring within months of insertion.
Other proximal assist devices such as heartstring (Guidant), Enclose (Novare), IPAD (Coalescent), and Corlink (Ethicon) that facilitate the performance of proximal anastomoses without aortic clamp are available.
In summary more work is needed to define the optimal conduit and the optimal patients for whom this technique using the Symmetry ACS should be used. Meanwhile hand suturing with partial aortic clamping remains the gold standard for creation of the proximal aortosaphenous anastomosis to which all new techniques and technologies must be compared. The ACS is an important addition to the armamentarium of the surgeon performing OPCAB by virtue of avoiding partial aortic cross-clamping. Early patency is comparable with that of historical controls using conventional hand-sewn techniques. A prospective randomized controlled trial using the ACS is under way at our institution to further investigate these issues and evaluate this interesting new technology.
| Discussion |
|---|
|
|
|---|
DR KATARIYA: To answer the question initially, I don't think I can be exact about what the nature of the problem was that caused these occlusions. Obviously as we all know occlusions and flows in these grafts are related to a number of other factors, not just the proximal anastomosis, the technique with which it is performed. The conduit itself may be to blame, the distal anastomosis may be to blame, as may be a whole host of other factors.
The device itself does have certain disadvantages. The proximal anastomosis must be done first. The vein comes off at an awkward angle, to say the least, from the aorta itself. And how this lies in the closed chest may also have a relation to the problem.
As far as recommendations on how to use this, again I would wait for a prospective randomized study to be completed before one can really look at how this compares with the conventional hands-on anastomosis.
DR HORVATH: And the use of Plavix in any cases?
DR KATARIYA: Most of these patients actually went back to the cardiologist and went home on aspirin. They did not all receive Plavix postoperatively.
DR VALAVANUR A. SUBRAMANIAN (New York, NY): It's somewhat concerning with the pattern of occlusion you get with this device. It is most commonly a flush occlusion at the aortic anastomotic opening, which is rare in the hand-sewn anastomosis still. This is probably due to an inherent problem with the concept of telescoping the vein through the aortic wall with these connectors. When you inject the aorta, you do not see any hood of the aortic end of the vein graft. Although the patency may be the same frequency but the nature of occlusion is an important concern.
DR KATARIYA: Thank you for your comments, Dr Subramanian. I totally agree with you. I think much more needs to be studied as far as the nature of the occlusion is concerned and the pattern of the occlusion in the grafts. Unfortunately in the connector devices or the connected anastomoses that were occluded, the cardiologist couldn't tell us anything more than that the graft was totally occluded.
DR HUMBERTO R. RAVELO (Long Beach, CA): I would like to congratulate the authors on a very timely presentation. I also wish to make some comments concerning the use of this sutureless proximal mechanical connector. We have had some experience with this devise which I believe is called Symmetry and is made by the St. Jude company.
First of all the use of this device is to be considered only in those selected cases in which you cannot not or should not manipulate the ascending aorta with a partial aortic occlusion clamp.
Secondly there is a degree of complexity in the loading and deployment of the device in its present design and thus the surgeon has to go through a learning curve before being able to use it effectively. The learning curve also involves strictly following the recommended criteria for vein selection and harvesting. Because the device's deployment on the ascending aorta always occurs at a 90-degree angle, we avoid placing it at the 11, 12 or 1 o'clock positions to minimize the possibility graft kinking, once the chest is closed. A more lateral deployment to either side avoids this problem by allowing for the graft to make a smooth curvature.
Finally in order to minimize failures with the intermittent selective use of the Symmetry device it is advantageous to have the Symmetry's technical representative present in the operating room whenever you elect to utilize it.
DR JOEL MORGAN (Winston-Salem, NC): Eighty-three patients were done in the first 6 months by one surgeon at my hospital using this device. They were a combination of on-pump and off-pump. Many patients had two, three, and even four connectors put on. Ten patients of 83 have come back. Three patients have had to be reoperated on. And in many of them the cardiologists will restudy them and you can see dye go down the native coronary, out the anastomosis, back up the vein graft to the aorta, and stop at the connector. Many of them have stenosis right at the connector. We have abandoned use of this device. I never used it but one surgeon used it. And I watched him use it, he's very careful, and I believe there's some inherent problems with this device.
DR KATARIYA: Thank you for your comments.
DR VARICK R. BERNSTEIN (Scranton, PA): Having had the unfortunate circumstance of a Symmetry device completely dislodging itself from the aorta 24 hours postoperating leading to a patient death, I was interested in that you had several deaths in your paper, which was an excellent paper, and my question is whether or not these patients had autopsies and what was the mechanism of death for these patients?
DR KATARIYA: We had autopsies in 2 of these 4 patients. One patient had an acute myocardial infarction postoperative day 1, actually less than postoperative day 1. He eventually was proven to have a hypercoagulable state. He died 6 days after surgery after having all his graft occluded, which we saw on an angiogram that was done 2 days after surgery.
The second patient who had an autopsy was actually a noncardiac death. The patient was discharged from the hospital at 6 days and actually had a blunt injury after a motor vehicle accident. He was brought into the trauma center and actually had an autopsy on the table. He was taken to the operating room for massive bleeding that probably had nothing to do with the coronary bypass operation. Unfortunately the other 2 patients who died did not have an autopsy.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Ricci and T. A. Salerno eComment: Aortic connectors in coronary artery surgery Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 672 - 672. [Full Text] [PDF] |
||||
![]() |
T. Puehler, S. Fraund-Cremer, J. Cremer, and A. Boening Successful six-year follow-up of a sutureless device for proximal anastomoses in a severely calcified ascending aorta Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 670 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J.L. Suyker and C. Borst Coronary Connector Devices: Analysis of 1,469 Anastomoses in 1,216 Patients Ann. Thorac. Surg., May 1, 2008; 85(5): 1828 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bergmann, K. Meszaros, S. Huber, P. Oberwalder, H. Machler, G. Schaffler, R. Rienmueller, and B. Rigler Forty-one-month follow-up of the Symmetry aortic connector system for proximal venous anastomosis J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 23 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Wolf, Y. Abu-Omar, B. P. Choudhary, D. Pigott, and D. P. Taggart Gaseous and solid cerebral microembolization during proximal aortic anastomoses in off-pump coronary surgery: The effect of an aortic side-biting clamp and two clampless devices J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 485 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Caputo, P. Narayan, and G. D. Angelini Conventional surgery with aortic cross-clamping MMCTS, March 15, 2006; 2006(0315): 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Skjelland, J. Bergsland, R. Lundblad, P. S. Lingaas, K. A. Rein, S. Halvorsen, J. L. Svennevig, E. Fosse, R. Brucher, and D. Russell Cerebral microembolization during off-pump coronary artery bypass surgery with the Symmetry aortic connector device J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1581 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kitamura, H. Okabayashi, M. Hanyu, Y. Soga, T. Nomoto, H. Johno, J. Nakano, T. Matsuo, M. Kai, and E. Umehara Early and midterm patency of the proximal anastomoses of saphenous vein grafts made with a Symmetry Aortic Connector System J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1028 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Aranki, P. S. Shekar, A. Ehsan, M. Byrne-Taft, and G. S. Couper Evaluation of the Enclose Proximal Anastomosis Device in Coronary Artery Bypass Grafting Ann. Thorac. Surg., September 1, 2005; 80(3): 1091 - 1095. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Izutani, M. Yoshitatsu, J. Kawamoto, and K. Katayama A case of ostial stenosis with the PAS-Port proximal anastomosis system in off-pump coronary artery bypass grafting Interactive CardioVascular and Thoracic Surgery, August 1, 2005; 4(4): 341 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D.L. Keenan, Y. Abu-Omar, and D. P. Taggart Bypassing the Pump: Changing Practices in Coronary Artery Surgery Chest, July 1, 2005; 128(1): 363 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Lev-Ran, R. Braunstein, R. Sharony, A. Kramer, Y. Paz, R. Mohr, and G. Uretzky No-touch aorta off-pump coronary surgery: The effect on stroke J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 307 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Cavendish, W. F. Penny, M. M. Madani, S. Keramati, O. Ben-Yehuda, D. G. Blanchard, E. Mahmud, A. Perricone, and S. Tsimikas Reply J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1141 - 1142. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |